Edition:
India

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.50USD
16 Feb 2018
Change (% chg)

$-0.22 (-3.85%)
Prev Close
$5.72
Open
$5.67
Day's High
$5.83
Day's Low
$5.36
Volume
31,846
Avg. Vol
61,638
52-wk High
$14.09
52-wk Low
$4.77

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 1.62 2.30 1.00 --
Quarter Ending Jun-18 4 1.62 2.40 0.80 --
Year Ending Dec-18 7 5.43 9.50 2.90 4.25
Earnings (per share)
Quarter Ending Mar-18 4 -0.57 -0.48 -0.63 --
Quarter Ending Jun-18 4 -0.56 -0.48 -0.63 --
Year Ending Dec-18 7 -2.29 -1.85 -2.86 -9.79
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 24 --
13 Week -20.95 -24.80 18 --
26 Week -24.27 -30.03 24 --
52 Week 15.92 -1.75 60 --
YTD 39.26 22.30 68 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.00%
# of Holders: 54
Total Shares Held: 24,951,800
3 Mo. Net Change: 80,474
# New Positions: 21
# Closed Positions: 13
# Increased Positions: 30
# Reduced Positions: 19
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.